Appeal 162-2024
Confirms rejection of dividend prescription
- Issued on
- December 9, 2025
- Issued by
- Court of Appeals

Overview
On December 9, 2025, the Third Civil and Commercial Court of Appeals reviewed the appeal filed by Avícola Villalobos, S.A. in a summary proceeding seeking a declaration of extinctive prescription to eliminate its obligation to pay dividends approved in favor of Lisa, S.A. at a shareholders’ meeting held on May 24, 2012.
The Court held that the appeal was unfounded and fully affirmed the April 2, 2024 judgment of the Twelfth Civil Court, concluding that Avícola failed to prove a definite and legally enforceable starting date required to compute prescription. The ruling confirmed that Lisa’s dividend rights remain enforceable and ordered Avícola to pay appellate costs.